Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Positive end-expiratory pressure (PEEP) is a mechanical ventilation strategy that involves maintaining a positive pressure in the airways at the end of expiration, which prevents alveolar collapse, improves oxygenation, increases functional residual capacity, and helps reduce ventilator-induced lung injury, particularly in diseases such as acute respiratory distress syndrome (ARDS) and other forms of hypoxemic respiratory failure. PEEP can have significant hemodynamic and pulmonary side effects if not titrated appropriately, including barotrauma, hypotension, and decreased cardiac output.
Mechanical prevention of alveolar collapse by maintaining positive pressure in the airways at end-expiration, leading to alveolar recruitment and improved ventilation/perfusion matching.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway patency via positive end-expiratory pressure.